Invention Grant
- Patent Title: Intermediates for imidazonaphthyridines
- Patent Title (中): 咪唑并吡啶的中间体
-
Application No.: US11999602Application Date: 2007-12-06
-
Publication No.: US07678918B2Publication Date: 2010-03-16
- Inventor: John F. Gerster , Kyle J. Lindstrom , Stephen L. Crooks , Philip D. Heppner , Gregory J. Marszalek , Peter V. Maye , Bryon A. Merrill , John W. Mickelson , Michael J. Rice
- Applicant: John F. Gerster , Kyle J. Lindstrom , Stephen L. Crooks , Philip D. Heppner , Gregory J. Marszalek , Peter V. Maye , Bryon A. Merrill , John W. Mickelson , Michael J. Rice
- Applicant Address: US MN Saint Paul US TN Bristol
- Assignee: 3M Innovative Properties Company,Graceway Pharmaceuticals, LLC
- Current Assignee: 3M Innovative Properties Company,Graceway Pharmaceuticals, LLC
- Current Assignee Address: US MN Saint Paul US TN Bristol
- Agency: Edwards Angell Palmer & Dodge LLP
- Agent Peter J. Manso; Weiying Yang
- Main IPC: C07D411/02
- IPC: C07D411/02
Abstract:
Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are disclosed.
Public/Granted literature
- US20080091010A1 Intermediates for imidazonaphthyridines Public/Granted day:2008-04-17
Information query
